DZ2815A1 - Protease inhibitors. - Google Patents

Protease inhibitors.

Info

Publication number
DZ2815A1
DZ2815A1 DZ990115A DZ990115A DZ2815A1 DZ 2815 A1 DZ2815 A1 DZ 2815A1 DZ 990115 A DZ990115 A DZ 990115A DZ 990115 A DZ990115 A DZ 990115A DZ 2815 A1 DZ2815 A1 DZ 2815A1
Authority
DZ
Algeria
Prior art keywords
protease inhibitors
protease
inhibitors
Prior art date
Application number
DZ990115A
Other languages
French (fr)
Inventor
Ashley E Fenwik
Andrew D Gribble
Robert Weiis Marquis Jr
Robert Witherington
Original Assignee
Smithkline Beecham Corp
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Smithkline Beecham Plc filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of DZ2815A1 publication Critical patent/DZ2815A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
DZ990115A 1998-06-12 1999-06-09 Protease inhibitors. DZ2815A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8905698P 1998-06-12 1998-06-12

Publications (1)

Publication Number Publication Date
DZ2815A1 true DZ2815A1 (en) 2003-12-01

Family

ID=22215426

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990115A DZ2815A1 (en) 1998-06-12 1999-06-09 Protease inhibitors.

Country Status (10)

Country Link
EP (1) EP1086083A4 (en)
JP (1) JP2002517485A (en)
AR (1) AR018652A1 (en)
AU (1) AU4564499A (en)
CA (1) CA2334652A1 (en)
CO (1) CO5040090A1 (en)
DZ (1) DZ2815A1 (en)
MA (1) MA24877A1 (en)
PE (1) PE20000725A1 (en)
WO (1) WO1999064399A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
EP1232155A4 (en) 1999-11-10 2002-11-20 Smithkline Beecham Corp Protease inhibitors
AU1474801A (en) 1999-11-10 2001-06-06 Smithkline Beecham Corporation Protease inhibitors
US6583137B1 (en) 1999-11-10 2003-06-24 Smithkline Beecham Corporation Protease inhibitors
AU2001243441B2 (en) 2000-03-21 2004-11-25 Smithkline Beecham Corporation Protease inhibitors
US20020156063A1 (en) * 2001-04-06 2002-10-24 Setti Eduardo L. Arylacetamido-ketobenzoxazole as cysteine protease inhibitors
US7282512B2 (en) 2002-01-17 2007-10-16 Smithkline Beecham Corporation Cycloalkyl ketoamides derivatives useful as cathepsin K inhibitors
EP2240491B1 (en) 2008-01-09 2015-07-15 Amura Therapeutics Limited TETRAHYDROFURO(2,3-b)PYRROL-3-ONE DERIVATIVES AS INHIBITORS OF CYSTEINE PROTEINASES
AR127031A1 (en) 2021-09-14 2023-12-13 Boehringer Ingelheim Int DERIVATIVES OF 3-PHENOXYAZETIDIN-1-IL-HETEROARYL PYRROLIDINE AND THE USE OF THESE AS A MEDICINAL PRODUCT

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK56296A3 (en) * 1993-11-09 1997-02-05 Merck & Co Inc Piperidinal, pyrrolidinal and hexahydro-1h-azepinal derivatives, manufacturing process thereof and pharmaceutical compositions containing them
US5770573A (en) * 1993-12-06 1998-06-23 Cytel Corporation CS-1 peptidomimetics, compositions and methods of using the same
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase

Also Published As

Publication number Publication date
AR018652A1 (en) 2001-11-28
CA2334652A1 (en) 1999-12-16
EP1086083A4 (en) 2001-09-26
CO5040090A1 (en) 2001-05-29
MA24877A1 (en) 1999-12-31
AU4564499A (en) 1999-12-30
JP2002517485A (en) 2002-06-18
WO1999064399A1 (en) 1999-12-16
PE20000725A1 (en) 2000-09-28
EP1086083A1 (en) 2001-03-28

Similar Documents

Publication Publication Date Title
MA24298A1 (en) PROTEASE INHIBITORS.
NO20012980L (en) protease inhibitors
NO995433D0 (en) Protease inhibitors
CU23049A3 (en) DIHYDROPIRIMIDINS.
ID29885A (en) SERINA PROBLEM PROTEASE
ZA992447B (en) Quinoxalinones as serine protease inhibitors.
NO20004550D0 (en) Enzyme inhibitors
ITTO991047A0 (en) REFRIGERATOR.
IT1312540B1 (en) COMPOSED.
ZA992448B (en) Quinoxalinones as serine protease inhibitors.
ATE534622T1 (en) ASPARTYL PROTEASE INHIBITORS
BR9904942B1 (en) hose.
NO995434D0 (en) protease inhibitors
NO995435D0 (en) Protease inhibitors
ID16104A (en) SERIN PROTEASE INHIBITORS.
MA26775A1 (en) SUBSTITUTED DIHETERO METALLOPROTEASES INHIBITORS.
NO995268D0 (en) protease inhibitors
DE59806475D1 (en) Urokinase INHIBITORS
NO20003814D0 (en) thrombin inhibitors
ATE252547T1 (en) MATRIXMETALLOPROTEINASE INHIBITORS
MA25758A1 (en) PROTEASE INHIBITORS.
DZ2815A1 (en) Protease inhibitors.
NL1008191A1 (en) Sealing.
IT1313300B1 (en) REFRIGERATOR.
MA26429A1 (en) PROTEASE INHIBITORS